Evidence for Humoral and Cellular Reactivity Against Keratin and Thyroglobulin in HTLV-I Infected Rabbits

References

• Gessain A., Brin F., Vernant J. C, Gout O., Maurs L., Calender A., De The G. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410
   PubMed Web of Science ®Google Scholar
• Hollsberg P. Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I. Acta Neurol. Scand. Suppl. 1997; 169: 86–93
   PubMedGoogle Scholar
• Poiesz B. J, Ruscetti F. W, Gazdar A. F, Bunn P. A, Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980; 77: 7415–7419
   PubMed Web of Science ®Google Scholar
• Tsukada N., Tanaka Y., Yanagisawa N. Autoantibodies to brain endothelial cells in the sera of patients with human T-lymphotropic virus type I associated myelopathy and other demyelinating disorders. J. Neurol. Sci. 1989; 90: 33–42
   PubMedGoogle Scholar
• Kitajima I., Osame M., Izumo S., Igata A. Immunological studies of HTLV-I associated myelopathy. Autoimmunity 1988; 1: 125–131
   PubMedGoogle Scholar
• Morgan O., Rodgers-Johnson P., Mora C., Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989; 2: 1184–1187
   PubMed Web of Science ®Google Scholar
• Green J. E, Hinrichs S. H, Vogel J., Jay G. Exocrinopathy resembling Sjorgren's syndrome in HTLV-1 tax transgenic mice. Nature 1989; 341: 72–74
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Watanabe T., Yamaguchi K., Takatsuky K., Yoshimura K., Shirao M., Nakashima S., Mori S., Araki S., Miata N. HTLV-I uveitis: a distinct clinical entity caused by HTLV-1. Jpn. l. Cancer Res. 1992a; 83: 236–239
   PubMedGoogle Scholar
• Mochizuki M., Watanabe T., Yamaguchi K., Yoshimura K., Nakashima S., Shirao M., Araki S., Takatsuki K., Mori S., Miyata N. Uveitis associated with human T-cell lymphotropic virus type I. Am. J. Ophthalmol. 1992; 114: 123–129
   PubMed Web of Science ®Google Scholar
• Kitajima I., Yamamoto K., Sato K., Nakajima Y., Nakajima T., Maruyama I., Osame M., Nishioka K. Detection of human T cell lymphotropic virus type 1 proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J. Clin. Invest. 1991; 88: 1315–1322
   PubMed Web of Science ®Google Scholar
• Ijichi S., Matsuda T., Maruyama L, Izumihara T., Kojima K., Niimura T., Maruyama Y., Sonoda S., Yoshida A., Osame M. Arthritis in a human T lymphotropic virus type 1 (HTLV-I) carrier. Ann. Rhem. Dis. 1990; 48: 718–721
   Google Scholar
• LaGrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990; 336: 1345–1347
   PubMed Web of Science ®Google Scholar
• Hanchard B., LaGrenade L., Carberry C, Fletcher V., Williams E., Cranston B., Blattner W. A., Manns A. Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years [letter]. Lancet 1991; 338: 593–594
   PubMedGoogle Scholar
• Mine H., Kawai H., Yokio K., Akaike M., Saito S. High frequencies of human T lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies. J. Mol. Med. 1996; 74: 471–477
   PubMed Web of Science ®Google Scholar
• Kawai H., Mitsui T., Yokoi K., Akaike M., Hirose K., Hizawa K., Saito S. Evidence of HTLV-I in thyroid tissue in an HTLV-I carrier with Hashimoto's thyroiditis. J. Mol. Med. 1996; 74: 275–278
   PubMed Web of Science ®Google Scholar
• Kawai H., Inui T., Kashiwagi S., Tsuchihashi T., Masuda K., Kondo A., Niki S., Iwasa M., Saito S. HTLV-I infection in patients with autoimmune thyroiditis (Hashimoto's thyroiditis). J. Med. Virol. 1992a; 38: 138–141
   PubMed Web of Science ®Google Scholar
• Akamine H., Takasu N., Komiya I., Ishikawa K., Shinjyo T., Nakachi K., Masuda M. Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukemia (ATL) and in HTLV-I carriers. Clin. Endocrinol. 1996; 45: 461–466
   PubMed Web of Science ®Google Scholar
• Kawai H., Saito M., Takagi M., Tsuchihashi T., Aril A., Kondo A., Iwasa M., Hirose T., Hizawa K., Saito S. Hashimoto's thyroiditis in HTLV-I carriers. Intern. Med. 1992; 31: 1213–1216
   PubMed Web of Science ®Google Scholar
• Palker T. J, Singer K. H., Vahlne A. Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus pi9 Gag protein. J. Acquir Immune Defic. Syndr. Hum. Retroviral. 1996; 11: 10–19
   PubMedGoogle Scholar
• Trihn D., Jeang K., Semmes O. J. HTLV-I Tax and cytokeratin: Tax-expressing cells show morphological changes in keratin-containing cytoskeietal networks. J. Biomed. Sci. 1997; 4: 47–53
   PubMed Web of Science ®Google Scholar
• Iwakura Y., Tosu M., Yoshida E., Takiguchi M., Sato K., Kitajima I., Nishioka K., Yamamoto K., Takeda T., Hatanaka M., Yamamoto H., Sekiguchi T. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991; 253: 1026–1028
   PubMed Web of Science ®Google Scholar
• Iwakura Y., Saijo S., Kioka Y., Nakayama-Yamada J., Itagaki K., Tosu M., Asano M., Kanai Y., Kakimoto K. Autoimmunity induction by human T cell leukemia virus type I in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J. Immunol. 1995; 55: 1588–1598
   Google Scholar
• Yamazaki H., Ikeda H., Ishizu A., Nakamaru Y., Sugaya T., Kikuchi K., Yamada S., Wakisaka A., Kasai N., Koike T., Hatanaka M., Yoshiki T. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env. pX genes of human T lymphocyte virus type I. Int. Immunol. 1997; 9: 339–346
   PubMed Web of Science ®Google Scholar
• Taguchi H., Sawada T., Fukushima A., Iwata J., Ohtsuki Y., Ueno H., Miyoshi I. Bilateral uveitis in a rabbit experimentally infected with human T-lymphotropic virus type 1. Lab. Invest. 1993; 69: 336–339
   PubMedGoogle Scholar
• Simpson R. M, Leno M., Hubbard B. S., Kindt T. J. Cutaneous manifestation of human T cell leukemia virus type I infection in an experimental model. J. Infect. Dis. 1996; 173: 722–726
   PubMedGoogle Scholar
• Chouchane L., Bowers F. S, Sawasdikosol S., Simpson R. M., Kindt T. J. Heat-shock proteins expressed on the surface of human T cell leukemia virus type I-infected cell lines induce autoantibodies in rabbits. J. Infect. Dis. 1994; 169: 253–259
   PubMed Web of Science ®Google Scholar
• Delaville M., Delaville J. Caracter de solubilite de la fraction albuminique du serum sanguin dans 1'alcool trichloracetique. Son application au dosage des diverses fractions proteiqucs. Ann. Pham. Fr. 1954; 12: 109–112
   PubMedGoogle Scholar
• Sawasdikosol S., Hague B. H, Zhao T. M, Bowers F. S, Simpson R. M, Robinson M. A., Kindt T. J. Selection of rabbit CD4*. CDS* TCR g6+ cells by in vitro transformation with human T lymphotropic virus type I. J. Exp. Med. 1993; 178: 1337–1345
   PubMedGoogle Scholar
• Zhao T. M, Robinson M. A, Bowers F. S., Kindt T. J. Characterization of an infectious molecular clone of human T-cell leukemia virus type I. J. Virol. 1995; 69: 2024–2030
   PubMedGoogle Scholar
• Zhao T. M, Robinson M. A, Bowers F. S., Kindt T J. Infectivity of chimeric human T-cell leukemia virus type I molecular clones assessed by naked DNA inoculation. Proc. Natl. Acad. Sci. USA 1996; 93: 6653–6658
   PubMedGoogle Scholar
• Muller S., Boire G., Ossondo M., Ricchiuti V., Smadja D., Vernant J. C., Ozden S. IgG autoantibody response in HTLV-I infected patients. Clin. Immunol. lmmunopathol. 1995; 77: 282–290
   PubMedGoogle Scholar
• Nishoka K., Sumida T., Hasunama T. Human T lymphotropic virus type 1 in arthropathy and autoimmune disorders. Arthritis Rheum. 1996; 39: 1410–1418
   PubMedGoogle Scholar
• Talarmin A., Nizou J. Y., Kazanji M. Antinuclear autoantibodies in human T-cell leukemia/lymphoma virus type I carriers in French Guiana. Arch. Virol. 1997; 142: 1713–1718
   PubMedGoogle Scholar
• Eiraku N., Hingorani R., Ijichi S., Machigashire K., Gregersen P. K, Monteiro J., Usuku K., Yashiki S., Sonada S., Osame M., Hall W. W. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. J. Immunol. 1998; 161: 6674–6680
   PubMedGoogle Scholar
• Manns A., Hisada M., LaGrenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353: 1951–1958
   PubMed Web of Science ®Google Scholar
• Pancake B. A, Zucker-Franklin D., Coutavas E. E. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease: a study of 50 patients. J. Clin. Invest. 1995; 95: 547–554
   PubMed Web of Science ®Google Scholar
• Pancake B. A, Wassef E. H., Zucker-Franklin D. Demonstration of antibodies to human T-cell lymphotropic virus-I tax in patients with the cutaneous T-cell lymphoma, mycosis fungoides, who are seronegative for antibodies to the structural proteins of the virus. Blood 1996; 88: 3004–3009
   PubMedGoogle Scholar
• Schocket A. L, Huff J. C, Carr R. I., Norris D. A. Humoral immunity in stage I mycosis fungoides: an increased incidence of lymphocytotoxic antibodies. Br. J. Dermatol. 1982; 107: 285–291
   PubMedGoogle Scholar
• Edlich R. F., Williams F. M. Global epidemic of human T cell lymphotropic virus type I (HTLV-I): its time for a vaccine!. Molecular Pathogenesis of HTLV-I, O. J. Semmes, M. L. Hammarskjold. AB1 Professional Publications, Arlington, VA 1999; 193–200
   Google Scholar
• Perl A., Colombo E., Dai H., Agarwal R., Mark K. A, Banki K., Poiesz B. J, Phillips P. E, Hoch S. O, Reveille J. D., Arnett F. C. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes: correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum. 1995; 38: 1660–1671
   PubMed Web of Science ®Google Scholar